Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 20/20 | 0.66 |
| ▸ | FNTB | P49356 | 20/20 | 0.66 |
| ▸ | PGGT1B | P53609 | 20/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8198361 | 0.99 | FNTA (0.65) | FNTAFNTBPGGT1B | |
| SCHEMBL3516881 | 0.86 | FNTA (0.68) | FNTAFNTBPGGT1B | |
| SCHEMBL3516041 | 0.85 | FNTA (0.67) | FNTAFNTBPGGT1B | |
| Hydrochloric Acid SCHEMBL8195496 | 0.85 | FNTA (0.67) | FNTAFNTBPGGT1B | |
| SCHEMBL5551924 | 0.85 | FNTA (0.64) | FNTAFNTBPGGT1B | |
| SCHEMBL8195315 | 0.83 | FNTA (0.59) | FNTAFNTBPGGT1B | |
| SCHEMBL8198311 | 0.82 | FNTA (0.47) | FNTAFNTBPGGT1B | |
| Hydrochloric Acid SCHEMBL8186937 | 0.81 | FNTA (0.47) | FNTAFNTBPGGT1B | |
| SCHEMBL3501213 | 0.80 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| Hydrochloric Acid SCHEMBL7674307 | 0.79 | FNTA (0.98) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1744751-A2 | METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2007-01-24 | — | — | EP | claimed |
| WO-2005089502-A2 | METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-09-29 | — | — | WO | claimed |
| WO-2000059930-A1 | A METHOD OF TREATING CANCER | MERCK & CO., INC. (US) | 2000-10-12 | — | — | WO | claimed |
| WO-2000034437-A2 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2000-06-15 | — | — | WO | claimed |
| EP-2155197-A2 | TREATMENT OF LYSOSOMAL STORAGE DISEASES | Link Medicine Corporation (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008112525-A2 | TREATMENT OF LYSOSOMAL STORAGE DISEASES | LINK MEDICINE CORPORATION (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2000059930-A1 | A METHOD OF TREATING CANCER | MERCK & CO., INC. (US) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000034437-A2 | INHIBITORS OF PRENYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 2000-06-15 | — | — | WO | disclosed |